Beximco Pharmaceuticals Limited gains GMP approval from TFDA

New Delhi, July 11, 2014 – Beximco Pharmaceuticals Limited (BPL) has become the first Bangladeshi company to receive Good Manufacturing Practices(GMP) accreditation from Taiwan Food and Drug Administration (TFDA).The company has received the approval for its oral solid, inhaler and sterile eye drop facilities.Taiwan FDA is considered as one of the most stringent regulatory agencies around the globe. BPL is a fast-growing manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids in Bangladesh. By receiving TFDA approval, BeximcoPharma has reached an important milestone validating BeximcoPharma’s commitment to quality and continuous efforts to expand its business around the globe.

Till date only a few generic companies have Taiwan FDA approval. Taiwan is encouraging access to generic drugs by offering accreditation to generic drug companies like BeximcoPharma.The company is currently exporting drug products to many countries around the world and its manufacturing facilities have already received GMP approvals from global regulatory authorities like AGES (EU), TGA (Australia) and ANVISA (Brazil).

Managing Director of BeximcoPharmasaid that “This approval is a testimony to the high standards of quality and compliance practices put in place by the company. This is an important step towards our aspiration to become a global generic drug player and particularly for building our presence in the regulated markets.” This accomplishment launches new marketing opportunities for BeximcoPharma’s products in ASEAN market including Taiwan, which is one of the advanced pharmaceutical markets in Asia. IGMPI